The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements
Cohen, Jillian Clare
Developing World Bioethics 2003 May; 3(1): 27-48
In this paper, we provide an overview of how the outcomes of the Uruguay Round affected the application of pharmaceutical intellectual property rights globally. Second, we explain how specific pharmaceutical policy tools can help developing states mitigate the worse effects of the TRIPS Agreement. Third, we put forward solutions that could be implemented by the World Bank to help overcome the divide between creating private incentives for research and development of innovative medicines and ensuring access of the poor to medicine. Fourth, we evaluate these solutions on the basis of utilitarian considerations and urge that equitable; pricing is morally preferable to the other solutions.
Showing items related by title, author, creator and subject.
Access to Medicines and the Role of Corporate Social Responsibility: The Need to Craft a Global Pharmaceutical System With Integrity Cohen-Kohler, Jillian Clare; Illingworth, Patricia (2008)
Cohen, Jillian Clare (2004-03)
Schroeder, Doris; Singer, Peter (2011-04)